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In the article “Scented Products Emit a 
Bouquet of VOCs,” Potera (2011) gave a 
broad overview of the work of Steinemann 
et al. (2010) regarding the quantification of 
volatile organic compounds (VOCs) from 
fragranced products. Unfortunately, crucial 
facts were omitted about the materials cited 
and the use of alternative substances. 
Potera (2011) quoted Steinemann et al. 
(2010), noting that some of the VOCs 
detected “are classified as toxic or hazardous 
by federal laws” and “a single fragrance in a 
product can . . . react with ozone in ambient 
air to form dangerous secondary pollutants.” 
Potera stated that limonene reacts with ozone 
to form formaldehyde but failed to mention 
that both limonene and pinene are naturally 
occurring materials found in citrus fruits and 
pine trees, respectively (Wei and Shibamoto 
2007). Fragrance materials are naturally vola-
tile; otherwise, they would not be detectable 
(Cometto-Muñiz et al. 1998). Langer et al. 
(2008) showed that exposure to limonene 
from peeling an orange is far greater than 
using limonene-scented cleaning products. 
These authors further showed that second-
ary organic pollutants formed from cleaning 
products exist in the lowest range of exposure 
and that a higher concentration of particulates 
is formed by peeling an orange. 
Potera (2011) quoted Steinemann et al. 
(2010), noting that “133 unique VOCs 
[were] identified among 25 products”; how-
ever, not all of the 133 VOCs are used as 
fragrance materials. For example, the highest 
reported concentration of d-limonene was 
135 mg/m3 (unidentified air freshener) in 
an experi  ment using conditions completely 
atypical of consumer use (Steinemann et al. 
2010).
Although, the U.S. Environmental 
Protection Agency does not issue safe expo-
sure limits, they report those from other 
agencies [National Institute for Occupational 
Safety and Health (NIOSH), Occupational 
Safety and Health Administration (OSHA), 
and American Conference of Governmental 
Industrial Hygienists (ACGIH)]. As of today, 
none of these agencies has issued a limit value 
for d-limonene. Germany (NIOSH 2005) and 
Sweden (International Agency for Research 
on Cancer 1999) have established limits for 
d-limonene of 110 mg/m3 and 150 mg/m3, 
respectively. Even under the adverse testing 
conditions reported by Steinemann et al. 
(2010), the d-limonene concentration of 
135 mg/m3 still falls within safe exposure.
Potera (2011) cited a telephone survey by 
Caress and Steinemann (2009) that attrib-
uted consumer health problems to the use of 
scented products; however, the percentages 
were not in context with the total population 
surveyed. Of those surveyed, 19% reported 
unspecified health problems and 11% noted 
irritation, all of which were subjectively 
ascribed to the use of scented laundry prod-
ucts (Caress and Steinemann 2009). While 
consumer complaints should be taken seri-
ously, one may question the investigators’ 
acceptance of these self-assessments in the 
absence of objective confirmation by medical 
testing.
Potera (2011) quoted Claudia Miller, 
who stated that “we need to find unscented 
alternatives ….” The fact is a variety of 
scented and unscented consumer products 
exist; thus, it is unnecessary to use poten-
tially dangerous home mixtures, such as vin-
egar (acetic acid) and baking soda (sodium 
bicarbonate), which was recom  mended as a 
replacement for commercial cleaning prod-
ucts (Potera 2011). However, the safe expo-
sure level for acetic acid, according to the 
ACGIH, NIOSH, and OSHA, is 25 mg/m3 
over 8 hr (OSHA 2007), which suggests a 
higher toxicity than for limonene. Health 
effects resulting from inhalation exposure 
to acetic acid include respiratory irritation, 
coughing, headache, and dizziness (Iowa 
State University 2000). 
In addition, symptoms include pulmo-
nary edema, chest pain, and hypotension; 
in contrast, d-limonene has not been associ-
ated with the development of any of these 
symptoms. Lacking published inhalation 
safety information for sodium bicarbon-
ate, NIOSH recommends using a respirator 
when working with the dry particu  late form 
(Mallinckrodt Baker Inc. 2009). 
Potera (2011) ended her article by quot-
ing Claudia Miller’s statement that “the best 
smell is no smell.” This is a very subjective 
assessment and cannot be charac  terized as an 
objective, science-based conclusion supported 
by available data.
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Breast Cancer Environment Centers 
and Advocacy
doi:10.1289/ehp.1103466
As Breast Cancer and Environment Research 
Center (BCERC) project leaders, we would 
like to address what we believe represents 
inaccuracies and omissions in the recent 
article by Baralt and McCormick (2010). 
Using self-  citations, the authors asserted that 
genes and environment were not included in 
breast cancer research before advocacy efforts 
emerged. Yet the environment has long been 
implicated in breast cancer etiology; for 
example, for > 50 years the laboratory model 
of mammary carcinogenesis has involved 
adminis  tration of environmental chemicals 
(Medina 2007). Further, the Long Island 
Breast Cancer Study Project (LIBCSP) was 
not the first environment–breast cancer grant, 
as suggested by Baralt and McCormick. The 
National Institute of Environmental Health 
Sciences issued such grants as early as 1991, 
including “Environmental Factors and Breast 
Cancer in High-Risk Areas” [Request for 
Applications (RFA) CA/ES-93-024] in 1993. 
The LIBCSP has been enormously 
productive, continuing even now, with 
> 100 scientific publications and $21 million 
in grant funding using LIBCSP resources. Correspondence
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Baralt and McCormick’s (2010) criticism of 
the LIBCSP ignores the rigorous review pro-
cess of National Institutes of Health grants, 
requiring an undeniable hypothesis, scien-
tific plausibility, and high probability of suc-
cess. What Baralt and McCormick described 
is the dissatisfaction of some (but not all) 
advocates with that research process during 
the initial years of the LIBCSP. 
Baralt and McCormick (2010) used the 
word “frustration” 16 times, without noting 
the impressive contributions of the BCERC 
Community Outreach and Translation Cores 
(COTC) projects. Advocacy and COTC 
in the BCERC since 2003 have resulted in 
extensive and innovative dissemination of 
knowledge and new ideas (Breast Cancer 
and the Environment Research Program 
2011). Mutual learning was facilitated by the 
participation of advocates and research staff 
in weekly staff meetings, monthly epidemi-
ology and COTC calls, 16 sub  committee 
meetings and calls, and organizing calls for 
the biannual meetings. Coordinated COTC, 
advocate, and scientific sessions were part 
of the biannual BCERC meetings. Rather 
than “frustration,” the past 7 years could be   
better summarized as an ongoing, inter-
active, collaborative, critical process of sci-
ence and advocacy–indeed a new paradigm 
of scientific method. 
As noted by Baralt and McCormick (2010), 
the 2002 RFA for BCERC did not require 
adherence to principles of community-based 
participatory research. The BCERC COTC 
members represented a range of experience in 
community-based participatory research; few 
had training in basic science. Each center devel-
oped different COTC models of community 
  involvement and engagement, not included 
by Baralt and McCormick in their article. The 
Bay Area COTC incorporated the principles of 
community-based, participatory research and 
used those principles to evaluate the extent to 
which the approach was participatory and to 
ascertain the benefits and challenges of the par-
ticipatory aspects of the project as perceived 
variously by community, advocacy, and scien-
tific partners (Van Olphen et al. 2009). Other 
centers used quite different models of com-
munity engagement and, accordingly, should 
be evaluated in a different fashion. Thus, it 
would have been appropriate for Baralt and 
McCormick (2010) to assess which model most 
effectively met the aims stated in the 2002 RFA. 
Another difference between centers was that, 
except for the Bay Area, the COTCs were part 
of a research or academic institution. Thus, we 
faced multiple challenges on how to effectively 
involve communities and advocates in research. 
Over the first 7 years, centers developed a con-
tinuum of strategies to create partnerships with 
the basic scientists and epidemiologists involved 
in BCERC.
Baralt and McCormick (2010) omitted 
important details describing their method-
ology from the article. Specifically, in their 
Table 1 they included demo  graphics about 
the sex and race/ethnicity of the investigators 
from BCERC centers, but no similar table 
charac  terized the participants in their study. 
[The Bay Area BCERC COTC included an 
African-American member, not four whites 
as Baralt and McCormick showed in their 
Table 1.] In addition, the authors did not dis-
cuss the involvement of advocates compared 
with non  advocates in activities of COTCs 
at the four centers. It was unclear whether 
survey participants included only scientists 
and advocates formally connected with the 
centers (e.g., those listed in their Table 1) or 
if they included non-BCERC scientists and 
advocates who attended the conferences. Also, 
if the respondents in 2005 and 2007 were 
completely different, as suggested, it was not 
appropriate to pool the data nor to report any 
changes over time. We support advocate par-
ticipation in research, and we recognize that 
methods for quantifying their contributions 
require unique approaches.
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Breast Cancer Environment 
Centers and Advocacy: Baralt and 
McCormick Respond
doi:10.1289/ehp.1103466R
Our findings regarding the Breast Cancer and 
Environment Research Centers (BCERCs) in 
which Wolff and Barlow are involved repre-
sent a broad overview of all four centers and 
are meant to portray several dimensions of the 
collabora  tive aspects of the work. In our article 
(Baralt and McCormick 2010), we aimed to 
advance the types of community-based par-
ticipatory research projects exemplified by 
these centers. With this aim, we presented an 
analysis of the collaborative process to under-
stand ways in which future funding can be 
better specified in the area of breast cancer 
and the environment. We sought to clarify 
how agencies can facilitate deepened partici-
pation in examining the potential under  lying 
issues that may affect participatory research 
projects, particularly with regard to a lack of 
understanding of and training in community- 
based participatory research on the part of 
many scientists and advocates, as well as 
potentially divergent priorities or desired out-
comes regarding the research. 
The findings reported in our article (Baralt 
and McCormick 2010) show a need to further 
articulate participatory methods. We sought 
to make it clear throughout the article that 
our analysis provides a unique contribution to 
the dialogue about improving the collabora-
tive process of participatory research projects. 
To this end, in a supplement to the article we 
provided recom  mendations that elaborated on 
the need for participants’ commitment to a 
participatory research approach, participatory 
research training for advocates and scientists, 
clearly defined roles for advocates in research, 
clearly defined decision-making processes, and 
delibera  tion and agreement on the allocation 
of funds. These recommenda  tions were based 
on our findings and what we heard from both 
advocates and scientists when we asked them 
about how the process could be improved 
upon in the future. 
Our analysis (Baralt and McCormick 
2010) does not represent our review of the 
scientific merits of the research being done 
in the centers or the entirety of environ-
mental breast cancer research, which has 
been in existence for many decades. The 
environmental breast cancer research to date 
has been of critical importance to science, 
policy making, and advocates who have 
also played an important role in advancing 
environ  mental breast cancer research begin-
ning in the 1990s. The rigorous National 
Institutes of Health review processes neces-
sary for each center to be funded assured that 
the BCERCs are innovative and compelling. 
Our research (Baralt and McCormick 
2010) provided a useful overview perspec-
tive on the collaborative process within the 
BCERCs, highlighting the strengths of the 
Bay Area BCERC, with the goal of improv-
ing similar projects in the future. We did not 
conduct ethnographic research in each center, 
which would have demon  strated more about 
the specific nature of collaboration in each 
location, as we noted that Van Olphen et al. 
(2009) nicely did with the Bay Area BCERC 
COTC. Rather, we provided an overview ofCorrespondence
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the collaborative process (not the outcomes of 
the scientific research or COTC translation 
and dissemination activities) by assessing the 
perceptions of the collaboration by advocates 
and scientists who responded to our survey 
and were interviewed. This overview of the 
centers demon  strated, as noted by Wolff and 
Barlow, that the centers varied with regard 
to their experience with community-based 
participatory research. Wolff and Barlow note 
in their letter that the Bay Area COTC was 
the one center that incorporated the princi-
ples of community-based research and, based 
on our research, provided the best example 
of successful advocate–scientist collaboration 
among the BCERCs. Therefore, throughout 
our article (Baralt and McCormick 2010) we 
used the Bay Area BCERC (as well as in the 
Supplemental Material, in which we elabo-
rated on a number of recommendations for 
future breast cancer–environment research 
collaborations) as a model for future collabora-
tive projects. Additionally, we were careful 
in noting the limitations of our methods,   
acknowledging that our findings reflect only 
our sample of possible respondents and there-
fore may not be generalizable to all center 
advocates and scientists. 
Our article (Baralt and McCormick 
2010) and recommendations are both in the 
spirit of furthering the work of the BCERCs 
and projects like the BCERCs that engage in 
the “ongoing, interactive, collaborative, criti-
cal process of science and advocacy,” as Wolff 
and Barlow describe their work with the 
BCERCs over the past 7 years. We encour-
age other researchers to continue investigat-
ing how environmental breast cancer research 
and other types of participatory projects can 
best serve the interests of science, advocates 
and policy-makers.
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Redefining Low Lead Levels 
doi:10.1289/ehp.1103489
In the January 2011 issue of EHP, 
Giddabasappa et al. (2011) reported that ges-
tational lead exposure (GLE) of C57BL/6 
mice produced selective non  monotonic 
increases in the numbers of rods and cone 
bipolar cells (BCs) in the adult retina. 
Interestingly, this increase was charac  terized 
by an inverted U-shaped dose–response 
curve. Moreover, findings of this study 
showed that GLE increases and prolongs pro-
liferation of retinal progenitor cells (RPCs) 
without decreasing apoptosis. Consequently, 
this phenomenon produced an adult retina 
with normal lamina  tion and a selectively 
increased number of rods and BCs. These 
results should be considered to define a more 
adequate risk assessment at low levels of lead 
exposure. In fact, other published articles 
have indicated that lead induced a biphasic 
dose–response relationship (Calabrese and 
Baldwin 2003). 
In experiments in Swiss mice using low-
level lead exposures similar to and lower than 
those used by Giddabasappa et al. (2011), we 
observed an increase in the number of red 
blood cells, in female gestational parameters, 
and in Th1 cytokine levels (Iavicoli et al. 
2003, 2004, 2006a, 2006b). For this reason, 
it would be interesting if Giddabasappa et al. 
could verify this increase in the number of 
neurons in the rod-signaling pathway at even 
lower blood lead levels (< 10 µg/dL). The 
findings of our studies were also implicated 
over several generations.
In any case, we agree with Giddabasappa 
et al. (2011) that their findings, as ours, raise 
complex issue for toxicologists, pediatricians, 
public health regulators, and risk assessors 
who need to incorporate the occurrence of 
such U-shaped dose responses in the hazard 
and risk assessment process. In this context, 
these findings could be explained by the 
hormesis phenomenon, which is a dose–
response relationship charac  terized by low-
dose stimulation and high-dose inhibition 
(Calabrese 2008, 2009).
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Editor’s note: In accordance with journal 
policy, Giddabasappa et al. were asked whether 
they wanted to respond to this letter, but they 
chose not to do so.